Neuroethics Studies Program

At the Intersection of Neuroscience, Medicine, and Society…

“The study of the causes of things must be  preceded by the study of things caused”

Hughlings Jackson, 1875

The past 10 years have borne witness to an accelerated pace of neuroscientific advancement, due in part to both 1) expansion within its constituent disciplines, and 2) the conjoinment of new disciplines, within both the sciences and humanities. At present, neuroscience is being increasingly employed to explore the basis of consciousness, cognition, emotion and behavior, and its techniques, technologies and knowledge are rapidly being translated into medical and social contexts to diagnose and treat neurological and psychiatric conditions, and to examine – and affect – decision-making, values, norms, mores, relationships, and the human condition at-large.

While neuroscience provides viable tools and information that can be applied – and of obvious benefit – to medicine, daily life and public health, public awareness of neuroscientific progress has also fostered more widespread anticipation, concern and anxiety about the ethical issues that such advances might incur. To be sure, numerous challenges lie at the intersection of neuroscience and society, and the field of neuroethics is dedicated to studies and applications of both 1) the neurological mechanisms of human ecology, morality and ethics, and 2) the ethical and social issues arising in and from neuroscientific research and its uses.

The Neuroethics Studies Program

It is in this light that the Neuroethics Studies Program of the Pellegrino Center for Clinical Bioethics serves as a resource and nexus for addressing the issues, questions, problems and resolutions fostered by applications of neuroscience in medicine, and public life and health upon the global stage.


Toward these ends, the Neuroethics Studies Program is dedicated to:

  1. Defining the pace and extent of neuroscientific developments, through assessment of actual capabilities, limitations and potential de-limitations of current – and near future – techniques and tools in research and various clinical and societal applications;
  2. Identifying, explicating and addressing those ethical problems arising from the use of neuroscientific approaches in medicine to study, affect, and in some cases alter the human condition, human predicament and/or human being;
  3. Evaluating and improving existing ethical systems, and developing ethical approaches to analyze, guide and govern the use of neuroscience and neurotechnology in medicine in an ever more pluralist world-culture;
  4. Providing neuroethics education and training to students and professionals in medicine, the sciences, humanities and liberal studies, and affording outreach to the general public and the media;
  5. Creating a resource and forum for scholarship and dialectical evaluation of neuroethical issues, questions and possible resolutions, through collaboration with visiting scholars, faculty and other institutions.

International Cooperation

The Neuroethics Studies Program cooperates with the Program in Integrative Health Promotions of the Coburg University of Applied Sciences, Coburg, Germany in scholarly activities sustaining a strong inter-disciplinary focus upon ethics and biomedical humanities.  Working together, this cooperation is forging a larger European network of scholarship, and provides opportunities to engage specific programs with cohort institutions.

James Giordano, PhD, MPhil
Chief, Neuroethics Studies Program, and Scholar-in-Residence, Pellegrino Center for Clinical Bioethics
Professor, Departments of Neurology and Biochemistry, Co-Director, O’Neill-Pellegrino Program in Brain Sciences and Global Health Law and Policy, Georgetown University Medical Center, Washington, DC, USA 


Nina Zeldes, PhD(c)
“Between Biomedicines – Negotiating Expectations and Cultural Beliefs on Healthcare among transnationals”

2020 Visiting Scholar
Diego Puricelli
“Neuroethical implications, issues and solution paths in synthetic biology”

2020 Visiting Scholar
Maureen Rhemann, PhD
“International investment in emerging neurotechnology: Economics and global ethics”

2019 Visiting Scholar
Pia Weiss
“Assessment-Intervention-Metrics – AIM: Development of an assessment and interventional paradigm for diagnosis and care of centralized chronic pain”

2019  Visiting Scholar
Danger Riley
“Toward a revision of ethical and policy stances to guide multicultural use of emerging biotechnology”

2018 Visiting Scholar
Ramona Christ
“Viability and value of medicinal cannabinoids in light of the current opioid crisis”

2018 Visiting Scholar
Paula Weibl
“Revisiting therapeutic use of psychedelics: Practical and ethical considerations”

2018  Visiting Scholar
 Lena Faltlhauser
 “Use and neuroethico-legal issues of EEG-based neurofeedback in post-TBI therapeutics”

2018 Visiting Scholar
Abram Brummet
“Developing curriculum in undergraduate neuroethics education”

2017 Visiting Scholar
Christina Röhrich
“The New Phenomenology as a viable philosophic  al ethics of health promotions”

2017  Visiting Scholar
Natalie Fahsen-Paetau
 “Neurodevelopmental effects of cell phone use: Impact upon cognitive function”

2017 Visiting Scholar
Maria Dütsch
“Toward development of safety and effectiveness guidelines for the extra-clinical use of nootropics”

2017 Visiting Scholar
Natalie Fahsen Paetau
“Patterns of neuro-cognitive interference induced by media device use during childhood”

2017 Visiting Scholar
Christina Röhrich
“Viability and value of the “new phenomenology” as philosophical basis for an ethics of health promotions”

2017 Visiting Scholar
Christoph Zeh
“Toward the use and guidance of virtual reality in health promotions: An optimization approach”

2017 Visiting Scholar
Caroline Mills
“Regulatory and ethical issues in the direction of commercial direct-to-consumer marketing of transcranial stimulation devices”

2017 Visiting Scholar
Christine Erwin-Grant
“Neuroethical concerns fostered by ontological issues in psychiatry”

2017 Visiting Scholar
Calvin Kraft
“What neuroscience can do, and what the law needs from neuroscience”

2017 Visiting Scholar
Mariel Kalkach Aparicio, MD
“Neuroethical issues in defining consciousness”

2017 Master’s Capstone Project Supervision
Stephanie Raynor
“On the validity, viability and use of x-radiation to affect signs, symptoms and processes of Alzheimer’s dementia”

2016 Visiting Scholar
Annemarie Weber
“Toward the use of resilience as a practice for Aristotelian balance in medicine”

2016 Visiting Scholar
Andreas Nagel, MS(c)
“Ethical issues in the use of virtual reality technologies in health promotions”

2016 Visiting Scholar
Kira Becker
“How functional is functional neuroimaging? Addressing methodological variability and validity”

2015-2017 Researcher-in-Residence
Katherine Shats, BS, LLB, LLM
“Brain science in global health, and global health law an”

2016 Visiting Scholar
Faisal Akram, MB, BS
“Constructing a New Paradigm in Preventive Psychiatry: Role of RDoC, Neuroimaging Data Repositories and Neuroethics”

2016-2017 Graduate Research Associate
Celeste Chen
“International neurotechnology research and development, strategic latency effects on global public health, and international relations, and international neuropolicy formulation and influence”

2016 Visiting Scholar
Christelle Khadra, RN, MSc, PhD(c)
“Development of a contemporrary neuroethical model for pediatric pain research through the lens of neurophilosophy”; PhD(c) at University of Montreal: “Effect of virtual reality on pain and anxiety in young children with burn injuries”

2015-2017 Visiting Scholar
Douglas McAdams, MD
“Neuroethics: definitions and applications in clinical neurology”

2015 Visiting Scholar
Yasmeen Alhasawi, PhD(c)
“Changing constructs of potentiality and identity in deaf individuals influenced by progressive developments in hearing-enabling neurotechnology”

2014 Visiting Scholar
Christian Carrozzo, MA
“Developments in neuroscience and ontologic values in neuroethics”

2014 Visiting Scholar
Koji Tachibana, PhD
“Neuroethical issues in use of decision-neurofeedback (Dec-NeF) as an approach to bioenhancement of moral cognition and action”

2014 Visiting Scholar
Samuel Velasquez, PhD(c)
“Philosophical and phenomenological perspectives of deep brain stimulation”

2014 Visiting Scholar
Lucy Botero, MD
“From the philosophy of medicine to a practical, clinical neuroethics”

2014 Visiting Scholar
Timothy Brindley, JD
“Neuroscientific and neurotechnologic international intellectual property rights and bioeconomic power”
2014 Visiting Scholar
Christine Fitzpatrick, MA
“Neuroscience, neurotechnology and neuroethics: Changing concepts and conceptualizations of finitude”

2014 Visiting Scholar
David Friedman, JD
“Neuroscientific and neurologic data pre- and post-mortem: Neuroethics, rights, and wrongs.

2014 Visiting Scholar
Joshua Harris, MA
“The Brain~mind in literature and culture: Historical, philosophical and ethical meanings and constructs for 21st Century society.”

2014 Visiting Scholar
Lucia Galvagni, PhD
“Ideals, identities and narratives in neuroethical discourses of enhancement”

2014 Visiting Scholar
Karen Herrera Ferrá, MD
“Neuroprevention? Defining neuroethical issues in the use of neurotechnology to mitigate recurrent violent crime in youths.”

2014 Visiting Scholar
Elisabetta Lanzilao, MA
“Cosmopolitan-communitarian perspectives, orientations and models in neuroethics”

2014 Visiting Scholar
Braden O’Shaughnessy
“Neurotechnology and neuroethical issues in chronic pain management”

2014 Visiting Scholar
Monika Schnabel
“Defining the opportunity and problem domains of deep brain stimulation research and practice: A qualitative and quantitative modeling approach to neuroethical analysis” 

2013 Visiting Scholar 
P. Justin Rossi
“Technical, economic and policy issues in Deep Brain Stimulation (DBS) for Tourette’s Syndrome – neuroethical concerns and apporaches”

2013 Visiting Scholar 
Hannah Joharchi, PhD (c)
“Neurotechnology, neurodiversity and ontology within the Deaf community – a neuroethical perspective”

2013 Visiting Scholar 
Anthony Schiavo
“Light sensitive polymer nanoparticles – technical and ethical considerations for responsible use in neuroscience”

2013 Visiting Scholar
Anvita Kulkarni
“Greater than its sum: Scientific convergence in neuroscience and its applications in predictive analysis for national security”

2013 Scholar
Danielle DeBacker, MA
“Indwelling brain stimulation: clinical, and ethico-legal issues and advancements”

2008 Visiting Scholar
Colin Higgins
“The serotonin 5-HT3 receptor: Structure, functions and neuroethical implications for pharmacotherapeutics”

2008 Visiting Scholar
Brian Wermcrantz
“Systems’ complexity in brain and emergent properties of mind: Merleau-Ponty redux”

2008 Visiting Scholar
Jolie Hoppe
“Use of propranolol and novel beta-blockers to mitigate PTSD in military personnel”

2008 Visiting Scholar
Liana Stec
“Involuntary psychiatric commitment: Ethical, legal and practical considerations”

2008 Visiting Scholar
Katie Lee
“Role of transcendence in bridging brain science and religion”

2008 Visiting Scholar
Roland Benedikter, PhD, DPhil
“Toward a neuroethics of meaning: Society and cultural implications of brain science”

2008 Visiting Scholar
Lindsay Moore
“Contemporary neuroscience: Informing educational policy and guidelines”

2008 Visiting Scholar
Adam James
“Manipulating memories: Treatment, enhancement and the ethics of existential loss and gain”

2007 Visiting Scholar
Anne Benvenuti, Ph.D.
“Toward an integration of the neural and the phenomenal in transcendent experiences”

2007 Visiting Scholar
Jill Kaspar
“Assessment of the objective and subjective dimensions of chronic pain: A mixed methods’ empirical, and philosophical study”

2007 Visiting Scholar
Josh Lindgren
“Pain, suffering and a Heideggerian notion of the person as event: Implications for the moral obligations of neurology and psychiatry”

2007 Visiting Scholar
Katia Braga, MA
“Comparative analysis of the history and philosophical basis of medical ethics in Brazil and the United States”

2006 Visiting Scholar
Richard Cox, Ph.D., M.D, D.Min.
“Toward a consilience of neuroscience and education”

2006 Visiting Scholar
Hans Werner Ingensiep, Ph.D., D.Phil.
“The concept of the ‘human vegetable’ and its implications for medical philosophy, ethics and practice”

2006 Visiting Scholar
Joan Engebretson, Dr.PH
“Philosophical premises and ethical dimensions of cultural negotiation in the clinical encounter.”

2006 Visiting Scholar
Laura Specker
“The neurocentric basis for categorical determination(s) of death: implications for neuroethics”

2006 Visiting Scholar
Joshua Sussman-Goldberg
“Self and identity: neural foundations of biological and psychological models”

2006 Visiting Scholar
Sheila Lee
“The basis of diagnosis in pain medicine and psychiatry: problems and potential”

2006 Visiting Scholar 
Peter Moskovitz, MD
“Toward a neurobiological theory of suffering”

Progress at the intersection of neuroscience and ethics can only occur through a process of intellectual discourse and dialectic. Toward this end, we encourage and welcome collaboration of colleagues from a variety of scientific and humanities disciplines. Opportunities exist for a limited number of researchers at all career levels (upper-undergraduate, graduate, and medical and law students, post-docs, junior, mid-level and senior faculty and/or clinicians) to become visiting scholars to undertake independent, mentored study on topics that are aligned and synergistic with our ongoing areas of interest. Visiting Scholar positions are available at the Center for Clinical Bioethics, Georgetown University Medical Center, Washington, DC.

Support/salary is not provided for scholars, and nominal fees are required to support administrative requirements. Prospective applicants are encouraged to develop and provide their own support (via salary, stipends, grants and/or other awards), and we welcome inquiries so as to assist potential applicants in developing such support from various funding resources.

Inquiries regarding opportunities for study as a visiting scholar should be directed to: Prof. James Giordano,

Inquiries should include a brief description of research interests and/or intended studies, proposed period and duration of stay. Please indicate “visiting study inquiry” in the subject line.

  • Examining and defining the role of neural substrates in moral decision-making.
  • The neuroethics of pain research and care.
  • The ethics of using of neuroscientific techniques and technologies to affect cognition, emotion and behavior; including the use of deep brain stimulation in various disease states, and to modify personality.
  • Addressing the use of neuroscience and neurotechnology as treatments, enablements, and/or enhancements, and to define normality and ontological status.
  • The neuroethics of basic, translational and clinical research, inclusive of issues such as the limits of knowledge, intellectual honesty, informed consent, and the use of neurocentric criteria to compel and sustain moral regard and treatment.
  • Use and misuses of neuroscience in international health and to affect global biopower and biopolitics.
  • The viability, validity and value of neuroscience and its technologies to define and change the human being, and the ethico-legal and social issues arising from such potential definition and change.
  • Development of a comprehensive 10-year international bibliography in neuroethics (in collaboration with Martina Darragh, Bioethics Library, KIE)

Ramirez-Zamora A, Giordano J, Gunduz A, et al. Advances in neurophysiology, adaptive DBS, virtual reality, neuroethics, and technology. Front Hum Neurosci 4(54): 1-17 (2020).

Calabrese EJ, Calabrese V, Tsatsakis A, Giordano J. Hormesis and ginkgo biloba (GB): Numerous biological effects of GB are mediated via hormesis. Ageing Res Rev 8(1): 4-16 (2020)

De Franco JP, Giordano J. Mapping the past, present, and future of brain research to navigate the directions, dangers, and discourses of dual-use. EC Neurol 12(1): 1-6 (2020).

DeFranco JP, DiEuliis D, Giordano J.  Neurodata: Part 1- Realities and risks. DefenceIQ, 13(4) (2020)

Gerstein D, Giordano, J. How to re-open America. CNN Opinions, 3(27): 2020.

DeFranco JP, Giordano J. The dark side of delivery; The growing threat of bioweapon dissemination by drones. DefenceIQ 13(1): (2020).

Venkatram V, Giordano J. The COVID Crisis: Implications for United States – and Global – Biosecurity. Department of Defense; Strategic Multilayer Assessment Group- Joint Staff/J-3/Pentagon Strategic Studies Group (April 2020)

Venkatram V, Giordano J. Contagion: COVID-19’s Impact on the Operational Environment. US Army Training and Doctrine Command (TRADOC) (April 2020).

DeFranco JP, DiEuliis D, Giordano J. Redefining neuroweapons: Emerging capabilities in neuroscience and neurotechnology. PRISM 8(3): 48-63 (2019).

Agraharam R, Giordano J. On the value of p: Toward improving statistical and translational significance – and value – of studies and the applicability of neurotechnology for precision medicine. Ethics Biol Engineer Med 9(1): 17-20 (2019).

Snow JJ, Giordano J. Aerosolized nanobots: Parsing fact from fiction for health security – a dialectical view.  Health Security 17(1): 74-76 (2019).

Calabrese EJ, Bhatia TN, Calabrese V, Dhawan G, Giordano J, Hanekamp YN, Kapoor R, Kozumbu WJ, Leak RK. Cytotoxicity models of Huntington’s disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies. Pharmacol Res 150: 104371 (2019).

DeFranco JP, DiEuliis D, Bremseth LR, Snow JJ. Giordano J. Emerging technologies for disruptive effects in non-kinetic engagements. HDIAC Currents 6(2): 49-54 (2019).

Ramirez-Zamora A, Giordano J, Boyden ES, et al. Modulation of brain networks and application of advanced neuroimaging, neurophysiology, and optogenetics. Front Neurosci: Neural Technol. 35 (2019).

DeFranco JP, Calabrese E, Giordano J. Restoring cerebral circulation and function postmortem: A multidimensional analysis. Brain Circ 5(2) 1-3 (2019).

Shook JR, Giordano J. Consideration of context and meanings of neuro-cognitive enhancement: The importance of a principled, internationally capable neuroethics. AJOB-Neuroscience 10(1): 48-61 (2019)

Sisbarro O, Giordano J. How stringent a P? Addressing p-values and the future conduct of translational research in neurology. EC Neurology 11(7): 2-6 (2019).

Asato S, Giordano J. Viewing p-value through the lens of the philosophy of medicine. Phil Ethics Humanities Med 14(8); (2019).

Giordano J, Snow JJ, DeFranco JP. Weaponized prions: Much ado about nothing, or big concerns about little proteins? DefenceIQ, 12(42): (2019).

Emanuel P, Walper S, DiEuliis D, Klein N, Petro JB, Giordano J. Cyborg Solder 2050: Human/Machine Fusion and the Implications for the Future of the DoD. CCDC-CBC/OUSD (October 2019).

Giordano J, Bremseth LR, DeFranco JP.  Dual- and non-kinetic use of Chinese brain science: Current activities and future implications. In: Petersen N. (ed. ) Chinese Strategic Intentions: A Deep Dive into China’s Worldwide Activities. Department of Defense; Strategic Multilayer Assessment Group- Joint Staff/J-3/Pentagon Strategic Studies Group (November 2019).

Weinberger AB, Cortes RA, Green AE, Giordano J. Neuroethical and social implications of using transcranial electrical stimulation to augment creative cognition. Creativity Res 30(3): 249-255 (2018).

Giordano J. Looking ahead: The importance of views, values, and voices in neuroethics –now. Camb Q Health Care Ethics 27(4): 728-731 (2018).

DiEuliis D, Lutes CD, Giordano J. Biodata risks and synthetic biology: A critical juncture. J Bioterrorism Biodef  9(1): 2-14 (2018).

Suskin ZD, Giordano J. Body-to-head transplant; a “caputal” crime? Examining the corpus of ethical and legal issues. Phil Ethics Humanities Med 13: 10 (2018).

Wu S, FitzGerald KT, Giordano J. On the viability and potential value of stem cells for repair and treatment of central neurotrauma: Overview and speculations. Front Neurol 9: 1-24 (2018).

Moskovitz P, Evers K, Giordano J. The problem with the hard problem: Thoughts on an oscillatory theory of consciousness. EC Neurol 10(4): 323-333 (2018).

Zeldes N, Dilger H, FitzGerald KT, Kohls NB, Moore E, Nöfer E, Giordano J. Transnational patients: Practical and ethical implications for medical practices and health promotions policy. World Med Health Pol 10 (2) 2-12 (2018).

Calabrese V, Santoro A, Trovato Salinaro A, Giordano J, Calabrese E. Hormetic approaches to the treatment of Parkinson’s disease: Perspectives and possibilities. J Neuro Res. 96 (3) 1-22 (2018)

Ramirez-Zamora A, Giordano J, Gunduz A, et al. Evolving applications, technological challenges and future opportunities in neuromodulation: Proceedings of the fifth annual Deep Brain Stimulation Think Tank. Front Neurosci 11(734)1-25 (2018).

Snow JJ, Giordano J. Public safety and national security implications of the horsepox study. Health Security 16(2): 1-3 (2018).

Kahn-Fuller, C, Shook JR, Giordano J. Moral mentation: What neurocognitive studies may really offer the internalism/externalism debate. J Cogn Neuroethics 5(2): 1-20 (2018).

Calabrese E, Iavicoli I, Calabrese V, Cory-Schlecta C, Giordano J. Elemental mercury neurotoxicity and clinical recovery of function: A review of findings, and implications for occupational health. Environ Res 163: 134-148 (2018).

Giordano J, Shook JR. Neuroethics: What it is, does – and should do. Health Care Ethics- USA 9(2): 15-19 (2018).

Calabrese V, Santoro A, Monti D, Crupi R, DiPaola R, Latteri S, Cuzzocrea S, Zappia, Giordano J, Calabrese E. Aging and Parkinson’s Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Rad Biol Med 115: 80-91 (2018).

Kushner T, Giordano J. If it only had a brain: What “neuro” means for science and ethics. Camb Q Health Care Ethics 27(4): 540-542 (2018).

Chen C, Andriola J, Giordano J. Biotechnology, commercial veiling, and implications for strategic latency: The exemplar of neuroscience and neurotechnology research and development in China. In: Davis ZS, Nacht M. (eds.) Strategic Latency: Red, White and Blue: Managing the National and International Security Consequences of Disruptive Technology. Livermore CA: Lawrence Livermore Press (2018), pp. 12-32.

DiEuliis D, Giordano J. Neurocognitive mechanism of self-disclosure. In: Canna S, Cabayan H (eds.) What Do Others Think, and How Do We Know What They’re Thinking? Department of Defense; Strategic Multilayer Assessment Group- Joint Staff/J-3/Pentagon Strategic Studies Group (March 2018).

Shook JR, Giordano J. Ethics transplants? Addressing the risks and benefits of guiding international biomedicine. AJOB-Neurosci 8(4): 230-232 (2017).

Gerstein D, Giordano J. Re-thinking the Biological and Toxin Weapons Convention? Health Security 15(6): 1-4 (2017).

Shook JR, Giordano J. Moral bioenhancement for social welfare: Are civic institutions ready? Front Sociol 2(21): 1-5 (2017)

DiEuliis D, Giordano J. Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity. Protein and Cell 15: 1-2 (2017).

Kraft C, Giordano J. Integrating brain science and law: Neuroscientific evidence and legal perspectives on protecting individual liberties. Front Neurosci 11: 1-10 (2017)

Evers K, Giordano J. The utility – and use – of neurotechnology to recover consciousness: Technical and neuroethical considerations in approaching the ‘hard question’ of neuroscience. Front Hum Neurosci 11(564): 2-5 (2017).

Herrera-Ferrá K, Giordano J. Recurrent violent behavior: Revised classification and implications for global psychiatry. Front Psychiatr 8(151) 1-4 (2017).

DiEuliis D, Giordano J. Why gene editors like CRISPR/Cas may be a game-changer for neuroweapons. Health Security 15(3): 296-302 (2017).

Giordano J. Weaponizing the brain: Neuroscience advancements spark debate. Nat Def, 6: 17-19 (2017).

Stein D, Giordano J. Neuroethics and global mental health: Establishing a dialogue. In: Illes J, Hossein S (eds.) Neuroethics: Anticipating the Future. Oxford: Oxford University Press (2017), pp. 591-602

Tennison M, Giordano J, Moreno J. Security threat versus aggregated truths: Ethical issues in the use of neuroscience and neurotechnology for national security. In: Illes J, Hossein S (eds.) Neuroethics: Anticipating the Future. Oxford: Oxford University Press (2017), pp. 531-553.

Shook JR, Giordano J. Neuroethical engagement on interdisciplinary and international scales. In: Racine E, Aspler J. (eds.) Debates About Neuroethics. NY: Springer (2017).

Giordano J. Neuroscience and technology as weapons on the twenty-first century world stage. In: Aviles W, Canna S. (eds.) Influence in an Age of Increasing Connectedness. p. 58-66. Department of Defense; Strategic Multilayer Assessment Group- Joint Staff/J-3/Pentagon Strategic Studies Group (July 2017).

Evers K,. Farisco M, Giordano J, Salles A, Dual Use in Neuroscientific and Neurotechnological Research. A Report on Background, Developments and Recommendations for Ethical Address, Assessment and Guidance of Human Brain Project Activities. European Union Human Brain Project  (March, 2017).

Akram F, Giordano J. Research domain criteria as psychiatric nosology: Conceptual, practical and neuroethical implications. Camb Q Health Care Ethics 26 (4) 1-10 (2017).

Calabrese EJ, Calabrese V, Giordano J. Role of hormesis in functional performance and protection of neural systems. Brain Circ, 3(1): 1-13 (2017).

Giordano J. Toward an operational neuroethical risk analysis and mitigation paradigm for emerging neuroscience and technology (neuroS/T). Exp Neurol 287 (4): 492-495 (2017).

Wurzman R, Yaden D, Giordano J.  Neuroscience fiction as eidolá: Social reflection and neuroethical obligations in depictions of neuroscience in film.  Camb Q Health Care Ethics — Neuroethics Now. 26(2): 292-312 (2017).

Palchik G, Chen C, Giordano J.  Monkey business? Development, influence and ethics of potentially dual-use brain science on the world stage.  Neuroethics.  10: 1-4 (2017).

Giordano J, Bikson M, Kappenman ES, et al. Mechanisms and effects of transcranial direct current stimulation.  Dose-Response.  1-22 (2017).

McAdams D, Hawley JT, Giordano J.  Neuroethics for neurology residents: Concepts and contingencies of a pilot neuroethics curriculum.  AJOB-Neuroscience.  8(1): 10-14 (2017).

CalabreseV, Giordano J, Crupi R, et al. Hormesis, cellular stress response and neuroinflammation in schizophrenia: Early onset versus late onset state.  J Neurosci Res. 95(1): 2-24 (2017). 

Giordano J.  Battlescape brain: Engaging neuroscience in defense operations.  HDIAC Journal.  3:4: 13-16 (2017).

Becker K, Shook J, Darragh M, Giordano J.  A four part working bibliography of neruoethics: Part 4 – Ethical issues in clinical and social applications of neuroscience.  Phil Ethics Humanities in Med.  12(1) (2017).

Rossi JP, Okun MS, Giordano J.  The problem of funding 0ff-label deep brain stimulation: Bait and switch tactics and the need for policy reform.  JAMA Neurol. 22: 12 (2016).

Bikson M, Paneri B, Giordano J.  The off-label use, utility and potential value of tDCS in the clinical care of particular neuropsychiatric conditions.  J Law Biosci.  1-5 (2016).

Calabrese V, Giordano J, Signorile A, Ontario ML, Castorina S, De PAsquale C, Eckert G, Calabrese EJ.  Major pathogenic mechanisms in vascular dementia: Roles for cellular stress response and hormesis in neuroprotection.  J Neurosci Res. 94(12): 1588-1603 (2016).

Giordano J, Becker K, Shook JR.  On the “neuroscience of ethics” — Approaching the neuroethical literature as a rational discourse on putative neural processes of moral cognition and behavior.  Neurol Neuromed.  1(6): 32-36 (2016).

Giordano J.  The value of patient benefit: Considerations of framing contingencies to guide the ethical use of DBS — a case analysis.  Camb Q Health Care Ethics — Clin Neuroethics. 25(4): 755-758 (2016).

Martin A, Becker K, Darragh M, Giordano J.  A four part working bibliography of neuroethics: Part 3 — “The ethics of neuroscience”. Phil Ethics Humanities in Med.  11(2) (2016).

Calabrese V, Giordano J, Ruggieri M, Berritta D, Trovato A, Ontario ML, Bianchini R, Calabrese EJ.  Hormesis, cellular stress response and redox homeostasis in autism spectrum disorders.  J Neurosci Res. 94(12): 1488-1498 (2016).

Giordano J. The neuroweapons threat. Bull Atomic Sci. 72(3): 1-4 (2016).

Wissam D, Giordano J, Rossi PJ, et al. Proceedings of the fourth annual Deep Brain Stimulation Think Tank: A review of emerging issues and technologies.  Front Integ Neurosci. 22 (2016).

Shook JR, Giordano J.  Moral enhancement? Acknowledging limitations of neurotechnology and morality.  AJOB-Neuroscience. 7(2): 118-120 (2016).

Shats K, Brindley T, Giordano J.  Don’t ask a neuroscientist about phases of the moon: Applying appropraite evidence law to the use of neuroscience in the courtroom.  Camb Q Health Care Ethics — Clin Neuroethics. 25(4): 712-725 (2016).

Rossi PJ, Giordano J, Walter BL, Okn MS. Ethical considerations of broadcasting awake brain stimulation surgery: Re-igniting a debate.  Brain Stim. (2016).

Herrera-Ferrá K, Giordano J. Re-classifying recurrent violent behavior? Considerations, caveats and neuroethics concerns for psychiatry and social engagement.  Acta Psychopathol. 2(1): 32-39 (2016). 

Armon E, Kohls NB, Giordano J.  On the viability of neurotechnology and mind-body methods in pediatric mental health: perspectives on integrating new tools to complement old techniques.  Eur J Integ Med. 8(2): 137-140 (2016).

Shook JR, Giordano J.  Neuroethics beyond normal. Performance enablement and self-transformative technologies.  Camb Q Health Care Ethics — Neuroethics Now. 25: 121-140 (2016).

Giordano J. A preparatory neuroethical approach to assessing developments in neurotechnology . AMA J Ethics 17(1): 56-61 (2015).

Stein DJ, Giordano J. Global mental health and neuroethics. BMC Medicine 13(1); (2015)

Darragh M, Buniak L, Giordano J. A four part working bibliography of neuroethics: Part 2 – Neuroscientific studies of morality and ethics . Phil Ethics Humanities in Med  10 (1); (2015).

Giordano J, Lanzilao E, Shook JR, Benedikter R. Guidare la neuroscienza e lo sviluppo della persona nel XXI secolo: Una prospettiva naturalistica e cosmopolita per la neuroetica. L’Arco di Giano 80: 147-164 (2015).

Shook JR, Galvagni L, Giordano J. Cognitive enhancement kept within contexts: Neuroethics and informed public policy . Frontiers Sys Neurosci 8: 1-8 (2014).

Avram M, Giordano J. Neuroethics: Some things old, some things new, some things borrowed…and to do . AJOB-Neuroscience 5(4): 1-3(2014).

Brindley T, Giordano J. International standards for intellectual property protection of neuroscience and neurotechnology: Neuroethical, legal and social (NELS) considerations in light of globalization . Stanford J Law Sci Policy 7:33 (2014).

Buniak L, Darragh M, Giordano J. A four part working bibliography of neuroethics: Part 1: Overviews and reviews – defining and describing the field and its practices . Phil Ethics Humanities in Med 9 (9); (2014).

Avram, M, Hennig-Fast K, Bao Y, Pöppel E, Reiser M, Blautzik J, Giordano J, Gutyrchik E. Neural correlates of moral judgments in first- and third-person perspectives: implications for neuroethics and beyond . BMC Neurosci 15 (39): (2014).

Loveless S, Giordano J. Neuroethics, painience and neurocentric criteria for the moral treatment of animals . Cambridge Q Healthcare Ethics 23(2): 163-172 (2014).

Giordano J. Ethical use of diagnostic technology: Balancing what’s new and what’s necessary. Am Fam Phys 90(1): 44-45 (2014).

Giordano J. The human prospect(s) of neuroscience and neurotechnology: domains of influence and the necessity – and questions – of neuroethics.  The Human Prospect 3(3): 2-19 (2014).

Rossi PJ, Okun MS, Giordano J. Translational imperatives in deep brain stimulation research: Addressing neuroethical issues of consequences and continuity of clinical care . AJOB-Neuroscience 5(1): 46-48 (2014).

Shook JR, Giordano J. A principled, cosmopolitan neuroethics: Considerations for international relevance . Phil Ethics Humanities in Med 9(1) (2014).

Giordano J, Kulkarni A, Farwell J. Deliver us from evil? The temptation, realities and neuroethico-legal issues of employing assessment neurotechnologies in public safety . Theoret Med Bioethics 35(1) (2014).

Giordano J. Respice finem: Historicity, heuristics and guidance of science and technology on the 21st century world stage . Synesis: A Journal of Science, Technology, Ethics and Policy. 4: E1-4 (2014).

Lanzilao E, Shook, J, Benedikter R, Giordano J. Advancing neuroscience on the 21st century world stage: The need for – and proposed structure of – an internationally relevant neuroethics. Ethics Biol Engineer Med 4(3): 211-229 (2013).

Fitzpatrick C, Giordano J. In saecula saeculorum? Bioscience, biotechnology and the construct of death. In; Tandy C. (ed.) Death and Anti-death; Vol 11: Ten Years After Donald Davidson . MO: Ria Press, (2013).

Fitz N, Giordano J. Analytic cognition. In: Keith KD. (ed.) Encyclopedia of Cross-cultural Psychology . NY: Wiley, (2013) p 355-370.

Giordano J, Rossi PJ, Benedikter R. Addressing the quantitative and qualitative: A view to complementarity – from the synaptic to the social. Open J Phil 3(4): 1-5(2013).

Rossi PJ, Novotny P, Paulick P, Plischke H, Kohls, NB, Giordano J. Decision technologies: Engineering capabilities and neuroethical considerations . J Ethics Biol Engineer Med. 6(4): (2013).

Brindley T, Giordano J. Neuroimaging – correlation, validity, value and admissibility: Daubert – and reliability – revisited . AJOB- Neuroscience 5(2): 48-50 (2014).

Howlader D, Giordano J. Advanced robotics: Changing the nature of war and thresholds and tolerance for conflict – implications for research and policy . J Phil Sci Law 13: 1-19 (2013).

Giordano J, Alam S. Ethical considerations in the globalization of medicine – An interview with Dr. James Giordano . BMC Medicine, 11: 69 (2013).

Anderson MA, Giordano J. Aequilibrium prudentis: On the necessity for ethics and policy studies in the scientific and technological education of medical professionals . BMC Med Education, 19(4): 279-283 (2013).

Jotterand F, Giordano J. Real-time functional magnetic resonance imaging (rtfMRI)-brain computer interfacing in the assessment and treatment of psychopathy: Potential and challenges. In: Claussen J (ed.) Springer Handbook of Neuroethics . NY ; Springer Verlag, (2013).

Giordano J. Pain and suffering: Körper and Leib, and the telos of pain care . Philosophy, Psychiatry, Psychol 19(4): 279-283 (2013).

Giordano J. Neuroimaging in psychiatry: Approaching the puzzle as a piece of the bigger picture(s) . AJOB-Neuroscience 3(4): 54-56 (2012).

Wurzman R, Giordano J. Differential susceptibility to plasticity: a ‘missing link’ between gene-culture co-evolution and neuropsychiatric spectrum disorders?  BMC Medicine 10:37(2012).  

Giordano J. Public health: History, theory and modern practices and challenges. In: Anheier K, Juergensmeyer M. (eds.) Encyclopedia of Global Studies . Fairfield CA: SAGE. (2012) p. 1414-1419.

Giordano J, Benedikter R, Kohls NB. Neuroscience and the importance of a neurobioethics: A reflection upon Fritz Jahr. In: Muzur A, Sass H-M. (eds.) Fritz Jahr and the Foundations of Integrative Bioethics. Münster; Berlin: LIT Verlag. (2012).

Giordano J, Benedikter R, Flores, N. Neuroeconomics: An emerging field of theory and practice. Eur Bus Rev. 7: 45-47 (2012).

Benedikter R, Giordano J. Neurotechnology: New frontiers for European policy . Pan Euro Network Sci Tech.3: 204-207 (2012).

Giordano J. Unpacking neuroscience and neurotechnology – instructions not included: neuroethics required . Neuroethics 4(3); (2012).

Plischke H, Du Rousseau D, Giordano J. EEG-based neurofeedback: The promise of neurotechnology and need for neuroethically-informed guidelines and policies . J Ethics Biol Engineer Med 4(2): 7-18 (2012).

Giordano J, Benedikter R. An early – and necessary – flight of the Owl of Minerva: Neuroscience, neurotechnology, human socio-cultural boundaries, and the importance of neuroethics . J Evolution and Technol 22(1): 14-25 (2012).

Giordano J. Neurobioetica: Riflettere su domande filosofiche all’intersezione di neuroscienze e societa. In: Farisco M. Neuroetica: Direzione, domande e risposte. U. Milano Press, (2012)

Giordano J. Integrative convergence in neuroscience: trajectories, problems and the need for a progressive neurobioethics. In: Vaseashta A, Braman E, Sussman, P. (eds.) Technological Innovation in Sensing and Detecting Chemical, Biological, Radiological, Nuclear Threats and Ecological Terrorism. (NATO Science for Peace and Security Series), NY: Springer, (2012).

Giordano J, Höver G. Conjoining interventional pain management and palliative care: Considerations for practice, ethics and policy. In: Van Norman G, Palmer S, Jackson S (eds.)Clinical Ethics in Anesthesiology. Cambridge, Cambridge University Press (2010).

Giordano J, Schatman ME. The ethics of pain management: A structural and functional approach. In: Manchikanti L (ed.) Interventional Approaches to Chronic Non-Spinal Pain. Paducah, KY, ASIPP Press; (2009).

Giordano J. Ethical obligations in infrared imaging research and practice. In: N. Diakedes, J. Bronzino  (eds.) Medical Infrared Imaging. Boca Raton: CRC Press; (2008)

Conwell T, Giordano J, Gulevich S. Functional infrared imaging of complex regional pain syndrome type I: Methodology, case studies, and clinical implications. In:  N. Diakedes, J. Bronzino (eds.) Medical Infrared Imaging. Boca Raton: CRC Press; (2008)

13. December 2019. Gesundheitsförderung: Prävention, Verbesserung, oder Selektion? Plenary lecture: Philosophisches Cafe, Coburg, GER

16. November 2019. Brave new neurotechnology – and the need for (a new) neuroethics. Invited plenary:  IEEE-SSIT Conference, Tufts University, Medford, MA.

29. October 2019. Neurotechnological developments and neuroethical obligations in assessing and treating Parkinson’s disease. Invited plenary:Michael J. Fox Foundation Conference, Gainesville, FL.

26. October 2019 What’s in name? Neuroethico-legal and social issues and responsibilities in assessing and treating PANS/PANDAS. Invited keynote: National PANS/PANDAS Symposium, Portsmouth, NH

24. September 2019. Emerging developments in neuro-engineering and current international neuroethical engagements. Invited plenary: Technical University of Munich, GER

5. September 2019. Global advancements in indwelling neuromodulation and international neuroethical issues, discourse and guidance. Invited plenary: Seventh Annual Deep Brain Stimulation Think Tank, Orlando, FL.

4. September,2019. Leveraging biomedical research and economics as disruptive operations in non-kinetic strategically latent engagements. Invited brief: SMA Group, Joint Staff, Pentagon, Arlington, VA.

27. August 2019. Deliver us from evil? On the use of neurocognitive science for public safety and national security. Invited plenary: Depts of Neurology, Psychiatry and Ethics, Medical College of Wisconsin, WI.

31. July, 2019. Neurocognitive sciences as disruptive instruments in non-kinetic engagements. Invited briefing: Global Futures Forum; Defense Threat Reduction Agency (DTRA), Arlington, MD

28. May, 2019. Pandora’s wager: Emerging neurotechnologies for health, operational protection and enhancement of future military operators. Invited plenary: DoD Biotechnology for Health and Performance Workshop, Washington, DC.

22. May 2019. Opportunities and risks of human-biotechnology engagement for performance optimization.  Plenary: Annual Pentagon Joint Staff Strategic Multilayer assessment Group Conference, Joint Base Andrews.

26. April, 2019. Treatment or enhancement and the good of the patient: Which rationale? Whence justice? Plenary: Pellegrino Symposium, Washington, DC.

16. April. 2019. Emerging neuroscience and technologies as threats: Assessing, analyzing and countering the risks to global security. Invited plenary: National Academy of Sciences, Washington, DC

11. April, 2019. The neuroweapons threat. Invited plenary: Intelligence Community Studies Board, National Academies, Washington, DC

9. April, 2019. Neuroethico-legal and social issues, challenges and opportunities in next generation non-invasive neuromodulation. Invited plenary: N3 Kickoff Meeting, DARPA, Arlington, VA

29. March, 2019. Accessible information and artificial intelligence: Threats to national security. Plenary: AI2 Symposium, Washington, DC

21. March, 2019. Brave and bold new brain science. Plenary: Maryland Science Center, Baltimore, MD.

15. March, 2019. Addressing radical leveling and emerging neurotechnologies as threats in non-kinetic engagements. Invited brief: SMA Group, J-3 Joint Staff, Pentagon.

7. March, 2019. Weaponizable neuroscience and technology. Invited lecture: IEEE Science and Society Meeting, Fairfax, VA.

24. January, 2019. A multi-thrust approach to assessing, analyzing and mitigating emerging technological threats.  Invited brief: J-5, US Special Operations Command (USSOCOM), Tampa FL

15. January, 2019. Radical leveling and emerging technologies as threats to global security. Invited brief: Defense Threat Reduction Agency (DTRA), Arlington, MD

14. December, 2018. Wie designt sich der Mensch? : Plenary lecture: Philosophisches Cafe, Coburg, GER

13. December, 2018. Minding neuroscience and technology on the 21st century world stage: Need for information, international neuroethics. Plenary: Homo Technicus/Technologicus Conference, Coburg, GER

13. November, 2018.  NEURINT: Neurocognitive approaches to optimizing performance of intelligence case officers and assets.  Invited brief: Office of the Director of National Intelligence, VA.

29. October, 2018. Emerging biotechnologies as threats to national security.  Invited briefing: OSD, Fairfax, VA.

16. October, 2018. Parsing neuroscience fact from fiction. Plenary lecture: American Science Writers Guild Meeting, Washington, DC

1. October, 2018.  Brave new brain science and the need for neuroethics now.  Music of the Mind Invited lecture, NY Optometry College, CUNY, NY

      17. September, 2018. Neuroscience and technology as weapons of mass disruption. Invited briefing: US Army INSCOM, Ft. Belvoir, VA

      11. September 2018. From the neuroscience of pain to a Neuroethics of pain research and care.  Invited lecture: International Association for the Study of Pain Conference, Boston, MA.

      31. August 2018. Toward ethical guidelines for the use of emerging neurotechnologies. Chair, IEEE Brain Project Neuroethics Sub-program Meeting, Washington, DC.

      27. August, 2018. Non-invasive neuromodulation for performance optimization: Current trends, technical considerations, neuroethico-legal issues.  Chair: NEUROMODEC Satellite Symposium, NY, NY.

      21. August 2018. “Embassy encephalopathy”: Possible use of neurotechnology for disruptive effects: Technical and ethical issues. Invited briefing: SOFWERX, Tampa, FL.

      2. August 2018. Engaging neurotechnologies for cognitive and behavioral optimization. Invited lecture and panel presentation: Science and Technology Policy Institute, Washington, DC.

      19 July 2018. Emerging neurotechnology; essential neuroethics. Invited plenary: National Institute for Standards and Testing, Rockville, MD

      17. May 2018. Updates on neuroethical, legal and social issues in this year of DBS research and clinical therapeutics. Plenary: Sixth Annual Deep Brain Stimulation Think Tank, Atlanta, GA.

      6. April 2018. Neuroscience and technology and the need for neuroethics. Plenary: Brain Health and Performance Summit, Ohio State University, OH.

      3. April 2018.  Weaponizable brain science: An international perspective and need for engagement. Invited lecture: Strategic Multilayer Assessment Annual Conference, Joint Base Andrews, MD.

      3. April 2018. Neuroethico-legal and social implications of the N3 Program.  Invited lecture: Defense Advanced Research Projects Agency N3 Project Proposers’ Day, Arlington, VA.

      30 March 2018.  Neuroplasticity, performance optimization and neuroethico-legal considerations. Invited lecture: Arizona State University DC Campus Center Workshop on Neuroplasticity and Performance, Washington, DC.

      20 March 2018. Building better brains: Neurotechnology and the need for informed neuroethics.  Invited Annual O’Malley Lecture, Loyola Marymount University, CA.

      13. March, 2018. Non-invasive brain stimulation to optimize cognitive and motor performance: Neuroethical issues and address. Invited plenary: US Air Force Office of Scientific Research Conference on Non-Invasive Neuromodulation and Performance Enhancement; Arlington, VA.

      10. March, 2018. PANS and PANDAS as neuro-inflammatory spectrum disorders: Implications for ethical assessment and care. Invited plenary and session chair: Common Threads Conference 2018; Columbia University, NY.

9. March 2018. Predictive and prescriptive neurology: Emerging neurotechnology and the need for neuroethics. Invited grand rounds: Medical College of Wisconsin; Milwaukee, WI

      14. December, 2017. Kühne neue Neurowissenschaft: Warum brauchen wir eine Neuroethik? Invited lecture: Philosophisches Cafe, Coburg, GER

1.December 2017. Picturing passing: Neuroimaging and neuroethical issues in brain death. Invited plenary: Brain Death: New Questions for Philosophy and Theology. Kennedy Institute of Ethics, Washington, DC.

21. November 2017. Neuroweapons: Viability in military and intelligence operations and neuroethico-legal considerations and concerns.  Invited briefing: US Army Special Operations Command, Washington, DC

2.November 2017. Neurotechnology futures: Research, uses and the need for neuroethics.  Invited lecture: IEEE Biomedical Section Meeting, Arlington VA

26. October 2017. Neuroethical issues in research and treatment of Parkinson’s disease.  Plenary: Parkinson’s Foundation Gala, Washington, DC

6. October 2017. Neuroweapons: Addressing the ethical issues of development and employment.  Invited keynote: Deutsche Bundeswehr Annual Technology Conference, Washington, DC

14. September 2017. Ethical issues in the international development and use of neurotechnology. Session chair and plenary: OECD Conference, Washington, DC.

5. August, 2017. Neuroethics: Addressing the good, bad and ugly applications of neuroscience in psychology. Keynote: American Psychological Association Conference, Washington, DC.

26. July 2017. Neuroscience and technology in national security and defense: Technical capabilities, neuroethical considerations. Invited plenary: US Army Training and Doctrine Command “Mad Scientists’” Conference, Washington, DC.

24. July 2017. (Neuro)ethical issues in use of controlled substances and novel techniques in interventional pain management. Invited plenary: American Society of Interventional Pain Physicians Meeting, Chicago, IL.

27. June 2017. Neuroscience in irregular warfare. Invited plenary: Center for Irregular Warfare and  Groups, US Naval War College, Newport, RI.

13.  June 2017. Brain science from bench to battlefield: The realities – and risks- of neuroweapons. Invited plenary: Center for Global Security Studies, Lawrence Livermore National Laboratory, Livermore, CA.

30. June, 2017. Neuroethical issues in the use of emerging neuroscience and technology in the assessment and treatment of Parkinson’s disease. Invited plenary: Parkinson’s Foundation Annual Conference, NY, NY.

30. May 2017. Ethical issues in biomedical research using vulnerable populations. Invited lecture: US Food and Drug Administration, Rockville, MD.

12. May, 2017. Brave new brain science: Practical and neuroethical considerations of neuro-cognitive performance optimization. Plenary teleconference: Universidad de Anahuac, Anahuac MX.

25. April, 2017. Neuroscience and neurotechnology as leverage for strategically latent influence upon the 21st century global stage. Plenary: SMA Strategic Influence Conference, Joint Base Andrews, MD.

20. April, 2017. Cutting edged neuroscience: Carefully considered Neuroethics. Invited lecture: Department of Neuroscience, Harvard University, Cambridge, MA.

7. April, 2017. Bold new brain science, and the birth – and growth – of Neuroethics.  Invited lecture: Osher Lifelong Learning Institute, University of Virginia, Charlottesville, VA.

24. March 2017. Phronesis in brain science: The importance and need for wisdom in Neuroethics. Plenary, Fourth Annual Pellegrino Symposium, Georgetown University, Washington, DC.]

24. January 2017. Neuroscience and technology in clinical neurology and psychiatry: Advances, problems and the need for neuroethics.  Invited Grand Rounds: University of California Irvine College Medical Center, Irvine, CA.

14. December 2016. Neuroscience and technology: Changing, brains, selves and minds. Invited lecture: Paracelsus School of Medicine, Nürnberg, GER.

9. November 2016. Ethico-legal issues in the use of neuro-cognitive science in national intelligence operations. Invited lecture: Defense Intelligence Agency, MD.

1. November 2016. Neuroethical issues in pain research and care. Invited lecture/grand rounds: Sutter Health/Pacific Coast Medical Center, San Francisco, CA

15. October, 2016.  PANDAS from bench to bedside to boardroom: Neuroscientific and Neuroethical and policy developments in guiding PANDAS research and treatment. Plenary: National PANDAS/PANS Network Conference, Washington DC.

19. July 2016. Integrative computational and neurocognitive science for intelligence operations: Viability, value and opportunities. Operational briefing: Joint Staff, The Pentagon.

30. June 2016. Fantastic neuroscience of tomorrow – Neuroethical obligations of today. Plenary: Neuroethics Network, Paris, FR.

25. June 2016. On science and the scientific method: Implications for studies of the brain~mind. Invited plenary lecture: Coburg University of Applied Sciences, Coburg, GER

12. June 2016. Developmental neurobiology of pain and analgesia: Implications for right and good use of neurotechnology in pediatric pain research and care. Plenary: Pediatric Pain Master Class: Children’s Hospital and Clinics of Minneapolis, MN.

19. April, 2016. Facilitating preconditioning through neurotechnology: Using new tools to optimize old tricks. Plenary: Annual Conference on Biological Preconditioning, University of Massachusetts, Amherst, MA.

15. April, 2016. On the “is” and the “ought” – On the validity and value of a neuroscience of human ecology. Plenary: Does Neuroscience have Normative Implications?

Conference, Illinois Institute of Technology, Chicago, IL.

14. April, 2016. Human cognitive enhancement: Cashing the reality check and maintaining a Neuroethical balance.  Invited lecture: Air Force Office of Scientific Research Conference on Human Performance Enhancement, Wright-Patterson AFB, Dayton, OH.

8. April, 2016. Brain mapping and therapeutics: Technical considerations, neuroethical concerns and constructs.  Plenary: Annual Meeting of the Society for Brain Mapping and Therapeutics, Miami, FL.

31. March 2016. Cyborgs, sentient machines and the need for Neuroethics. Invited lecture: Villanova University, PA

9. March 2016. DBS: IDEs, HDEs and the Rs, Ws and Cs in right and good paths from bench to bedside. Plenary: Fourth Annual National Deep Brain Stimulation ThinkTank; Gainesville, FL.

19. February 2016. Toward a new neuroethics.  Plenary: Association for Practical and Professional Ethics, 25th Annual Meeting; Arlington, VA.

18. December 2015. Toward a structural and functional ethical paradigm for globally relevant health promotions.  Invited lecture: Blockseminar, Coburg University of Applied Sciences and Arts, Coburg, GER

17. December 2015. Tapfer neue Gehirn: Neurowissenschaft, Neurotechnologie, Glück, die Gute Leben und der wichitgkeit des Neuroethik. Plenary and panel discussion: Philosophischen Cafes, Fugenlos-Coburg University for Applied Sciences and Arts, Coburg, GER

11. December 2015. Ethical systems’ basis and utility in a global  health promotions’ model. Invited lecture: Blockseminar, Coburg University of Applied Sciences and Arts, Coburg, GER

4. December 2015. Trancranial electrical stimulation: Neuroethical issues and a paradigm for risk assessment and mitigation. Invited lecture: DuPont Summit, Washington, DC.

20. November 2015. Neuroethical issues in direct-to-consumer use of tES. Invited panel lecture: US Food and Drug Administration,  Public Hearing on Neuromodulatory Device Use, Rockville, MD.

19. November 2015. Neuroscience, neurotechnology and the human in transition: The need and value of neuroethics. Vivian B. Lamb Memorial Lecture, Villanova University, Philadelphia, PA.

30. October 2015. Operationalizing neuro-cognitive science in national intelligence and security. Plenary and conference chair: Operational Aspects of Neuro-Cognitive Science. Strategic Multilayer Assessment Group, Joint Staff, Pentagon, Arlington, VA.

19. October 2015. Neuroethics: Addressing issues in neuroscience and neurotechnology from bench to bedside and beyond.  Invited lecture: Loyola Marymount University, Los Angeles, CA

16. October 2015. (Neuro)psychiatry in prisons: Balancing BRAIN, Bentham, Burgess and beneficence.  Invited Plenary: International Neuroethics Society Meeting, Chicago, IL

 7. October 2015. Neuroethics: Navigating – and guiding – the good, bad and potentially ugly of neuroscience. Annual McCormack Lecture: St. Joseph’s University, Philadelphia, PA

28. July 2015. Innovative neurotechnology: Potential, problems and the need for a preparatory neuroethics.  Plenary lecture. DARPA Restoring Active Memory Program Conference, Chicago, IL.

21. July 2015. Engaging neuro-cognitive science in national security and intelligence operations against ISIL. Invited Briefing. Pentagon Joint Staff/J-3 Office, Arlington VA.

8. July 2015. Neuromodulatory technology for CNS protection, function and optimization: Technical aspects and neuroethical issues.  Plenary lecture and conference co-chair, First Annual Conference on Neuroprotection.  University of Massachusetts, Amherst, MA

24. June 2015. Developmental neurobiology of pain and analgesia: From neuroscience to a neuroethics of pediatric pain care.  Plenary lecture. Pain Master Class, Children’s Hospital and Clinics’ Foundation of Minneapolis, Minneapolis, MN

27. May 2015. Neuroscience and neurotechnology – a gathering storm: On the need for neuroethical guidance in informing international policies toward preparedness. Plenary Lecture: Workshop on Biotechnology, Strategic Latency and National Security. Lawrence Livermore National Laboratories, Livermore, CA

27. April 2015. Minding Gray Matters: Addressing neuroethico-legal issues arising in the BRAIN initiative. Chair; Conjoint Symposium: Presidential Commission for the Study of Bioethical Issues-Georgetown University Medical Center; Washington, DC

14. April 2015. Pandora’s pause: Neuroethical preparation for using neuroscience in law. Invited Lecture: Harvard-MGH Center for Bioethics Symposium; Boston, MA

18. March 2015. Facilitating investigator initiated research in deep brain stimulation: Neuroethical groundwork and approaches. Plenary Lecture, National Deep Brain Stimulation Think Tank. University of Florida Medical School, Gainesville, FL.

19. February 2015. Neurotechnology on the global stage: Competition, co-optation and the need for neuroethically-informed international policy.  Plenary lecture; US-Iranian Delegation Summit, US Department of State, Washington DC

10. January 2015. Neuromodulation: Toward neuroethically sound  risk analysis and management. Invited plenary: NEUROMODEC Conference, City College, CUNY, NY.

12. November 2014. Sentient systems, social regard, and the viability of neuroethics. Plenary, and session co-chair. American Association for Artificial Intelligence Conference, Washington, DC.

11. October 2014. Dementia, developments in neuroscience and neurotechnology, and the need for neuroethics. Keynote address: Fifth Annual Dementia Conference; Holy Cross Hospital, Silver Springs, MD.

9. October 2014. Technical and neuroethical challenges in pediatric pain control: Addressing harms of omission and commission. Plenary: Cleveland Clinic Annual Conference on Chronic Neurological Conditions. Cleveland, OH.

2. October 2014. Neuroethics: Addressing and guiding brain science in society. Sigma Xi Distinguished Miller Lecture, Alfred University, Alfred NY.

1. October 2014. Artificial Intelligence: On the need – and importance – of neuroethics.  Plenary, and conference co-chair: Machines, Minds and Meaning Symposium; Washington DC.

23. September 2014. Battlescape brain: Neuroscience and neurotechnology in national security, intelligence and defense. Envision Leadership Forum in National Security Studies, Pentagon City, VA.

16. September 2014. Neuroethics- Issues at the intersection of neuroscience, medicine and society. Tenth Annual Stiernotte Memorial Lecture; Quinnipiac University Medical School and College of Arts and Sciences, CT.

11. August 2014. Placebo responses: From neurobiology to neuroethics’ considerations in clinical practice. Invited lecture: Mind-body Studies Special Interest Group; National Institutes of Health, Bethesda, MD

7. August 2014. Neuroscience in the  globalized public sphere: The need for neuroethics in policy. Invited lecture: O’Neill Institute for National Global Health Law, Washington, DC. Plenary lecture: Envision Leadership Forum in Science, Johns Hopkins University, Baltimore, MD.

19. July 2014. Neuroscience and neuroethics: Navigating brain research and its application’s in society. Plenary: Envision Leadership Summit in Healthcare and Society. Columbia University, NY.

2. July 2014. Brave new brain sciences: Neurotechnology and the need for neuroethics. Plenary lecture. Envision Leadership Summit in Science and Technology. University of Maryland, College Park, MD.

28. June 2014. Neuroethics: Issues and resolutions at the intersection of brain science and society. Plenary lecture: Envision Leadership Forum in Medicine and Health, Johns Hopkins University, Baltimore, MD.

20. June 2014. From the heuristics of neuroscience to a pragmatic animal neuroethics. Invited lecture and session chair: International Neuroethics Network Conference, Paris, France.

12. June 2014. Neuroethical issues in pediatric pain care. Plenary lecture. Pain Master Class, Children’s Hospital and Clinics of Minnesota, Minneapolis, MN.

26. May 2014. Human-machine interfaces (HMU): Mit Bio-engineering gegen das “schwache Glied” in der Hochleistungsluftfahrt angehen. Plenary Lecture: Raum- und Luftfahrtstechnik Abteilung; Technisches Universität-Braunschweig, GER.

20. May 2014. The brain as the new battlescape: Neuroscience and neurotechnology in national security, intelligence and defense applications. Invited briefing: Joint Staff, US Department of Defense, Washington, DC, USA.

23. April 2014. Scanning brains and reading minds? On the potential (benefits, burdens and harms) of neurotechnology – and the importance of neuroethics. Sigma Xi Distinguished Lecture, Quinnipiac University School of Medicine and Health Sciences, Quinnipiac, CT.

14. March 2014. Neurotechnology in public safety: Protecting our homes and nations. Plenary Lecture, Brain Matters Conference, Vancouver, CAN.

6. March 2014. DBS: The translational paradox, and neuroethical grounding of policy and regulation. Plenary Lecture, International Think Tank on Deep Brain Stimulation. University of Florida Medical School, Gainsville, FL.

19. December 2013. Bio-engineering, neurotechnology and the importance of neuroethics. Plenary lecture: Division of Mechatronics, Munich University of Applied Sciences, Munich, GER.

17. December 2013. Neuroethics – Navigating the good, the needed and the nasty of neuroscience in society. Public Plenary Lecture: Coburg University of Applied Arts and Sciences, Coburg, GER.

17. December 2013. Neurotechnologies for health promotion: Benefits, burdens and the need for neuroethics.  Department of Integrative Health Promotions. Coburg University of Applied Arts and Sciences, Coburg, GER. 

15. November 2013. Imaging pain: Technical capabilities; neuroethical issues. Sigma Xi Distinguished Lecture, A.T Still University of Health Sciences, Kirksville, MO.

14. November 2013. BRAIN: A “feet on the ground” view of global initiatives in neurotechnology. Plenary: Strategic Multilevel Assessment Group 8th Annual Conference on Strategic Initiatives. US Joint Base Andrews, MD.

25. October 2013. Brave new BRAIN: National agendas in neuroscience and the need for neuroethics. Distinguished Lecture: “Discoveries” Public Lecture Series, Georgetown University, Washington, DC.

18. October 2013. Neuroecology, neuroscience and neurotechnology in programs of international influence and violence deterrence.  Plenary, and Conference Co-chair. US Department of Health and Human Services’ Conference on Neuro-influence and Neuro-deterrence. Washington, DC

19. September 2013. Bioscience as demiurge: Homo-biotechnicus and technology revisited.  Plenary: National Academy of Sciences’ DC Arts and Sciences Evening Rendezvous, Washington, DC.

21. August 2013. Neuro-cyber technologic fusion, preparedness and neuroethics. Plenary: First Annual conference on Human-Cyber Fusion. L’Enfant Plaza, Washington, DC

6. August 2013. Brave new BRAIN: “Neuro-technology” redux and neuroethical responsibilities. Invited lecture: National Science Foundation Café Scientifique, Arlington, VA.

23. July 2013. Neuroweapons and neuroethics in national security and defense. Plenary: American Association for the Advancement of Science Neuroscience and Ethics conference; Washington, DC.

19. July 2013. Brave new brain? Neuroscience, neuroculture and neuroethics. National LeadAmerica Educational Program in Science, Technology and Medicine: Columbia University, NY.

14. July 2013. Neuroscience, society and the importance of neuroethics. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine; Johns Hopkins University, Baltimore, MD

12. July 2013. Mind, machine and morality: Science, cyborgization and 21st century society. National LeadAmerica Educational Program in Science, Technology and Medicine: Columbia University, NY

11. July 2013. Brave new brain? Neuroscience, neuroculture and neuroethics. National LeadAmerica Educational Program in Science, Technology and Medicine: Columbia University, NY.

4. July 2013. Brain science, technology and the future of humanity. Progress, problems and neuroethical obligations. Plenary: National Youth Leadership forum, Washington, DC.

28. June 2013. Cyborgization and the cyborg society. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine; Johns Hopkins University, Baltimore, MD.

27. June 2013. Neuroscience, society and the importance of neuroethics. Invited lecture: National LeadAmerica Educational Program in Science, Technology and Medicine; Johns Hopkins University, Baltimore, MD.

24. June 2013. Neuroethics- at the intersection of science, society and morality. Plenary: National Youth Leadership forum, Washington, DC.

10. June 2013. Battlescape brain: Weaponizable neurotechnologies and the need for neuroethics. Plenary: US Naval War College, Newport, RI.

9. June 2013. Neurotechnology and neuroethical promise- and problems – in pediatric pain research and therapeutics. Plenary: Second International Conference on Opioids, Harvard University Medical School, Boston, MA.

5. June 2013. The neuroscience of pediatric pain, and the neuroethics of pediatric pain care. Invited lecture: Childrens’ Hospital and Clinics of Minnesota; Pain Master Class, Minneapolis, MN.

23. May 2013. Neurotechnology- treatment, enablement and enhancement: Neuroethical implications for the deaf community. Invited plenary: Munich University of Applied Sciences, Munich, GER.

10. May 2013. Brain Research – The good, the bad, the ugly – and need for neuroethics. Invited lecture: President’s Commission for the Study of Bioethical Issues, Washington, DC

7. May 2013. Frontier science and the responsible conduct of research: Implications for specialized populations. Plenary: Annual Symposium on  Research Ethics; Gallaudet University, Washington, Dc.

3. May 2013. Neuroscience, neurotechnology and the neurophilosophy and neuroethics of the human person. Invited lecture: Krok Foundation Conference on Science, Persons and Morality. University of Notre Dame, IN.

29. April 2013. Dual use issues in neuroscience and the role of neuroethics education, training and practices. Invited lecture: Science, Security and Policy Studies Group, American Association for the Advancement of Science (AAAS), Washington, DC.

26. April 2013. Neuroscience: trajectories, valences and the need for neuroethics. Plenary; North Dakota Academy of Sciences, Grand Forks, ND.

13. April 2013. Neuroethics: Two traditions and the viability of a naturalistic meta-ethics. Invited lecture: “The Human Prospect Conference”, Columbia University, NY.

2. April 2013. A right and good healing: Philosophical and ethical bases of an integrative medicine. Plenary: Medical Humanities Program, University of Texas Medical Branch, Galveston, TX.

1. April 2013. Predictive neuroscience: Possibilities and challenges – and the importance of neuroethics. Invited lecture: John McGovern Center for Health, Humanities and Ethics, University of Texas Health Sciences Center, Houston, TX.

1. April 2013. Systems neuroscience, integrative convergence and pragmatic neuroethics. Invited lecture: Systems and Complexity Studies Program, Dept of Graduate Nursing, University of Texas Health Sciences Center, Houston. Houston, TX.

29. March 2013. Neuroethics- Issues at the intersection of mind, machines and morality. Invited Keynote: Shenandoah Biotechnology Symposium, Harrisonburg, VA.

8. March 2013. Predictive neurtotechnology and the prevention of social violence: Minority Report, and real-world neuroethics. Radio Interview: Dr. Keith Maguire, USA Syndicated News Radio

1. March 2013. Medicine and global health: Issues and ethics. Invited international podcast: BioMed Central Online:

28. February 2013. Ethical considerations in the globalization of medicine. Invited podcast: BioMed Central Online – BMC Medicine.

9. February 2013. Predictive neurotechnologies: Facts, fictions and fears of scanning brains and reading minds. Invited lecture; National Capital Association of Skeptics- National Science Foundation, Arlington, VA

29. January 2013. Battlescape Brain: Neuroweapons and the neuroethics of national security and defense. Plenary: American Association for the Advancement of Science: Policy and Analysis Directorate; Washington, DC.

25. January 2013. Neuroscience The good, the bad, the ugly – and the need for neuroethics. Invited Keynote: McGill University, Montreal, Canada.

21. December 2012. Neuroscience, neurotechnology and the enablement of moral decision-making.Invited Lecture: Parmenides Stiftung, Pullach, Germany.

20. December 2012. Integrative biotechnology and brain-machine interactions: Bioengineering the weak-link out of high performance aircraft flight: Practical and ethical considerations. Invited Plenary: Luftfahrtssystems Abteilung, Div. BioFabrik u. Technik, Technisches Universität-München, Munich, Germany

3. December 2012. Frontier science, forward-looking ethics – beyond the precautionary principle. IGERT Program Plenary, University of New Mexico, Albuquerque, NM